Cancer research
New research out of Taiwan has made significant strides in improving the detection accuracy of breast cancer through mammography. The study, led by researchers at National Tsing Hua University, employed deep learning-based computer-aided diagnosis systems to evaluate the effectiveness of transfer learning, image preprocessing techniques, and the latest You Only
Cancer research
A clinical trial has been registered to study the efficacy of Apixaban in preventing venous thromboembolism (VTE) in patients with pancreatobiliary malignancies. The trial, registered with the Clinical Research Information Service (CRiS) in the Republic of Korea, aims to determine whether Apixaban can effectively prevent VTE in these high-risk patients.
Cancer research
Researchers at the Guangzhou University of Chinese Medicine have developed a machine learning-based model to predict breast cancer incidence risk by incorporating both personal clinical factors and peripheral blood biochemical biomarkers. The study aimed to enhance the understanding of breast cancer risk by identifying novel risk factors using machine learning
Cancer research
Researchers from the University of Tennessee, Knoxville, have made significant progress in using artificial intelligence and machine learning to provide treatment plans to breast cancer patients more quickly. By analyzing pathology reports and other clinical records, the team has developed a system that determines the extent of breast cancer in
Cancer research
The COVID-19 pandemic has accelerated the shift to at-home stool tests for colorectal cancer screening, particularly among patients with limited access to healthcare facilities. Research from Stanford University has analyzed the use of stool tests before and after the pandemic, revealing significant changes in screening rates and patient behavior. The
Cancer research
Researchers at Yonsei University College of Medicine have successfully performed a rare and complex surgery to treat gastric cancer accompanied by a splenic mass. The procedure, which combines splenectomy and robotic subtotal gastrectomy, has yielded promising results, allowing for the safe resection of tumors while preserving digestive functions and quality
Cancer research
National Cancer Institute (NCI) has announced an interventional clinical trial to investigate the effectiveness of adding induction chemotherapy to the standard treatment of chemotherapy and radiation for high-risk locally advanced cervical cancer. The Phase 3 trial, led by principal investigator Jyoti S Mayadev, aims to enroll 336 participants from the
Cancer research
Researchers at the Medical University of South Carolina's Hollings Cancer Center have made a significant breakthrough in the treatment of acute myeloid leukemia (AML), a fast-growing and aggressive form of blood cancer. Led by pediatric hematologist-oncologist and bone marrow transplant expert Sophie Paczesny, M.D., Ph.D., the
Cancer research
Cancer patients undergoing contemporary systemic anticancer therapies are at high risk of developing venous thromboembolism (VTE), a potentially life-threatening condition. To identify patients with high VTE risk who may benefit from primary thromboprophylaxis, several risk assessment models (RAMs) have been developed. However, the performance of these RAMs has not been
Cancer research
Researchers from Tarbiat Modares University in Iran have made a significant discovery in the field of breast cancer diagnosis using machine learning algorithms. According to their study, the early detection of breast cancer is a major challenge due to its varying symptoms among different types of cancer. However, the use
Cancer research
A recent study published in the Frontiers in Medicine journal has found that deep learning models, particularly convolutional neural networks (CNNs) and transformer-based architectures, demonstrate excellent performance in classifying breast cancer pathology images. The research highlights the potential of these models in enhancing clinical decision-making in breast cancer management. According
Cancer research
Researchers have found that individuals diagnosed with nonmetastatic low-risk prostate cancer, treated according to the NCCN Clinical Practice Guidelines in Oncology, are likely to survive their cancer for their remaining life expectancy. In fact, 90% of patients in this category were found to have a high likelihood of survival. The
